Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1951467-29-0

Post Buying Request

1951467-29-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1951467-29-0 Usage

Description

[2-methyl-5-(β-D-glucopyranosyl)phenyl][5-(4-fluorophenyl)-2-thienyl]methanol, also known as (2S,3R,4R,5S,6R)-2-(3-((5-(4-Fluorophenyl)thiophen-2-yl)(hydroxy)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, is a complex organic compound characterized by its unique molecular structure. It is an impurity found in Canagliflozin, a medication used for treating type 2 diabetes.

Uses

Used in Pharmaceutical Industry:
[2-methyl-5-(β-D-glucopyranosyl)phenyl][5-(4-fluorophenyl)-2-thienyl]methanol is used as an impurity in the production of Canagliflozin (C175190), a sodium/glucose cotransporter 2 (SGLT2) inhibitor, for the treatment of type 2 diabetes. The presence of this compound in Canagliflozin is significant as it may affect the drug's efficacy, safety, and overall quality.
As an impurity in the pharmaceutical industry, [2-methyl-5-(β-D-glucopyranosyl)phenyl][5-(4-fluorophenyl)-2-thienyl]methanol is important for quality control and regulatory compliance. Ensuring that the levels of this impurity are within acceptable limits is crucial for maintaining the safety and effectiveness of Canagliflozin as a diabetes treatment.

Check Digit Verification of cas no

The CAS Registry Mumber 1951467-29-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,9,5,1,4,6 and 7 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1951467-29:
(9*1)+(8*9)+(7*5)+(6*1)+(5*4)+(4*6)+(3*7)+(2*2)+(1*9)=200
200 % 10 = 0
So 1951467-29-0 is a valid CAS Registry Number.

1951467-29-0Upstream product

1951467-29-0Downstream Products

1951467-29-0Relevant articles and documents

Canagliflozin impurity compound and preparation method thereof

-

Paragraph 0034; 0035, (2018/10/11)

The invention relates to a novel type 2 diabetes resistant drug canagliflozin impurity compound [2-methyl-5-(beta-D-glucopyranose)phenyl][5-(4-fluorophenyl)-2-thienyl]methyl hydroperoxide (a compoundof a formula IV) and a preparation method thereof, and application of the impurity compound serving as a canagliflozin quality control reference standard substance.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1951467-29-0